Advertisement
Advertisement
U.S. markets open in 6 hours 55 minutes
Advertisement
Advertisement
Advertisement
Advertisement

High Fusion Inc. (SPLIF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00890.0000 (0.00%)
At close: 11:01AM EST
Advertisement
Full screen
Loading interactive chart...
  • Newsfile

    High Fusion Announces Application for Management Cease Trade Order Is Denied

    Toronto, Ontario--(Newsfile Corp. - November 17, 2022) - High Fusion Inc. (CSE: FUZN) (OTC Pink: SPLIF) ("High Fusion" or the "Company") announces that its request for a Management Cease Trade Order ("MCTO") was denied on November 16, 2022, by the Ontario Securities Commission ("OSC").Pursuant to National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), the Company notified OSC on November 15, 2022, that it anticipated a delay in filing its financial statements for ...

  • Newsfile

    High Fusion Announces Application for Management Cease Trade Order

    Toronto, Ontario--(Newsfile Corp. - November 15, 2022) - High Fusion Inc. (CSE: FUZN) (OTC Pink: SPLIF) ("High Fusion" or the "Company") announces today that it has made an application to the Ontario Securities Commission to approve a temporary management cease trade order ("MCTO") under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"), which, if granted, will prohibit trading in securities of the Company by its Chief Executive Officer and Chief Financial Officer so long ...

  • Newsfile

    High Fusion and Its Psychedelics Subsidiary Neural Therapeutics Enter into Arrangement Agreement

    Toronto, Ontario--(Newsfile Corp. - November 4, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce that it has entered into a definitive arrangement agreement (the "Agreement") with Neural Therapeutics Inc. ("Neural") with respect to the distribution of a approximately one quarter of High Fusion's shareholdings in Neural to High Fusion shareholders ("Transaction").High Fusion CEO John Durfy commented, "This strategic spin-out of our holdings in Neural, f

Advertisement
Advertisement